IL33 and toxoplasmosis: The release of IL-33 can occur as a consequence of tissue damage associated with allergic inflammation or viral infection (Bonilla et al., 2012; Silver et al., 2016), and during toxoplasmosis, IL-33 levels correlated closely with levels of parasite replication and host cell lysis.